hydrocortisone acetate has been researched along with Prostatic Neoplasms in 1 studies
hydrocortisone acetate: RN given refers to cpd without isomeric designation
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Labrie, F | 1 |
| Dupont, A | 1 |
| Bélanger, A | 1 |
| Cusan, L | 1 |
| Brochu, M | 1 |
| Turina, E | 1 |
| Pinault, S | 1 |
| Lacourciere, Y | 1 |
| Emond, J | 1 |
1 other study available for hydrocortisone acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
Anti-hormone treatment for prostate cancer relapsing after treatment with flutamide and castration. Addition of aminoglutethimide and low dose hydrocortisone to combination therapy.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Flutam | 1989 |